Swiss officials: Covid vaccine protects for 12 months
A man receives a plaster after getting his jab in Bern
Keystone / Peter Klaunzer
Coronavirus vaccines could offer at least 12 months of protection against all forms of the virus, a top Swiss health official says. This increases the former official line of six months of protection.
The Federal Vaccination Commission has concluded that people are protected for at least a year against infection – and more than that against severe cases, said Virginie Masserey, head of the Federal Office of Public Health’s Infectious Diseases Section, at a press conference on Tuesday.
It will therefore not be necessary to have a booster jab before 2022, she added.
Ordinances on the issue will be changed to reflect this change of view.
More than half of adults have already received at least one dose of the vaccine, Masserey explained. This rises to at least 80% for vulnerable groups. The vaccination campaign is proceeding well, with around 100,000 vaccinations a day, the official said. There are no indications that vaccine willingness is dropping off.
Covid certificate
The development of the forgery proof Covid certificate is also going well, with more than 650,000 already sent out, Masserey said. “We are confident that all those who want can have access to a certificate by the end of the month,” she said. This is to be given to anyone who has been vaccinated, has recovered from or has recently tested negative for coronavirus. The validity length of the certificate would also be changed due to the protection advice change.
Trend, variants
Meanwhile downward trend in case numbers is continuing. There were 243 reported Covid-19 casesExternal link on Tuesday, 14 hospitalisations and two deaths. New infections have stayed below 1,000 since May 26.
Masserey added that until now the number of cases linked to new variants of the coronavirus like the Delta variant were relatively low. Vaccines were also effective against these variants, but people still had to be careful as not everyone had yet been vaccinated, she added
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
US storm continues to sweep through Swiss stock market
This content was published on
The Swiss stock market continued to trade in the red mid-afternoon on Monday, following in the wake of the world's stock markets, which fell heavily as a result of the trade war launched by Donald Trump.
This content was published on
The referendum committee announced in Bern on Monday that it had collected more than 60,000 signatures against the e-ID project. The initials still need to be approved.
This content was published on
The number of offences committed by minors in canton Ticino, southern Switzerland, rose by over 20% in 2024 compared to the previous year.
Swiss trout and pike found with excessive PFAS levels
This content was published on
Trout and pike in the lakes of western Switzerland contain excessive levels of the chemical group PFAS. This could jeopardise their saleability.
Swiss unions call for shorter days for construction workers
This content was published on
Construction workers need shorter days, say Swiss trade unions. Demonstrations are planned in Zurich and Lausanne on May 17.
Rapeseed restrictions cause problems for Swiss farmers
This content was published on
More and more Swiss farmers are abandoning rapeseed cultivation because they lack the means to protect the sensitive plants from pests.
Tariffs: Swiss index SMI down sharply in pre-market trading
This content was published on
The trade war unleashed by US President Donald Trump is causing a sell-off. According to experts' calculations, the leading Swiss SMI index is likely to fall by around 2%.
This content was published on
US-based biotech company Moderna is applying for the use of its Covid-19 vaccine for adolescents aged 12 to 17 in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.